ELV · Elevance Health, Inc. · Executive Compensation
$439.95
-5.33 (-1.20%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$95.05B
Shares
216.06M
Volume · Oct 23
1.17M
Avg daily vol (3M)
1.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $22,582,314 |
| Mark Kaye | EVP and Chief Financial Officer (CFO) | $7,992,077 |
| Peter D. Haytaian | EVP and President, Carelon and CarelonRx | $7,098,488 |
| Felicia Norwood | EVP and Chief Health Benefits Officer | $7,073,965 |
| Morgan Kendrick | EVP and President, Commercial and Specialty Health Benefits | $6,661,911 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $20,471,976 |
| Mark Kaye | EVP and Chief Financial Officer (CFO) | $6,873,144 |
| Peter D. Haytaian | EVP and President, Carelon and CarelonRx | $6,345,127 |
| Felicia Norwood | EVP and President, Government Health Benefits | $6,288,946 |
| Morgan Kendrick | EVP and President, Commercial and Specialty Health Benefits | $5,793,474 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $21,889,039 |
| Mark Kaye | EVP and Chief Financial Officer (CFO) | $14,859,201 |
| Mark B. Kaye | EVP and Chief Financial Officer (CFO) | $12,359,201 |
| John Gallina | Former EVP and Chief Financial Officer (CFO) | $8,165,416 |
| Blair Todt | EVP, Chief Legal and Administrative Officer | $8,112,972 |
| Peter D. Haytaian | EVP and President, Carelon and CarelonRx | $6,978,051 |
| Felicia Norwood | EVP and President, Government Health Benefits | $6,475,408 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $20,931,081 |
| John Gallina | Former EVP and Chief Financial Officer (CFO) | $7,641,837 |
| Gloria M. McCarthy | EVP and Chief Administrative Officer | $6,426,376 |
| Peter D. Haytaian | EVP and President, Carelon and CarelonRx | $6,387,729 |
| Felicia Norwood | EVP and President, Government Health Benefits | $6,386,987 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $19,348,241 |
| Peter D. Haytaian | EVP and President, Carelon and CarelonRx | $7,888,858 |
| John Gallina | Former EVP and Chief Financial Officer (CFO) | $6,141,280 |
| Gloria M. McCarthy | EVP and Chief Administrative Officer | $5,923,134 |
| Felicia Norwood | EVP and President, Government Health Benefits | $5,833,937 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $17,109,952 |
| Gloria M. McCarthy | EVP and Chief Administrative Officer | $5,530,661 |
| John Gallina | EVP and Chief Financial Officer (CFO) | $5,401,735 |
| Peter D. Haytaian | EVP and President, Carelon and CarelonRx | $5,387,111 |
| Felicia Norwood | EVP and President, Government Business Division | $5,236,403 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $15,473,139 |
| Felicia Norwood | EVP and President, Government Business Division | $7,922,755 |
| Gloria M. McCarthy | EVP and Chief Administrative Officer | $5,247,126 |
| John Gallina | EVP and Chief Financial Officer (CFO) | $5,109,053 |
| Peter D. Haytaian | EVP and President, Diversified Business Group and IngenioRx | $5,076,966 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $14,184,276 |
| Peter D. Haytaian | EVP and President Commercial and Specialty Division | $5,936,543 |
| Gloria M. McCarthy | EVP and Chief Administrative Officer | $5,436,787 |
| John Gallina | EVP and Chief Financial Officer (CFO) | $5,153,866 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Gloria M. McCarthy | EVP and Chief Administrative Officer | $5,816,686 |
| John Gallina | EVP and Chief Financial Officer (CFO) | $5,478,983 |
| Peter D. Haytaian | EVP and President Commercial and Specialty Division | $5,422,957 |
| Gail Boudreaux | President and Chief Executive Officer (CEO) | $2,166,253 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Amy W. Schulman | independent director | Appointed | 2025-12-10 |
| Steven H. Collis | independent director | Appointed | 2025-07-28 |
| Mark Kaye | Executive Vice President and Chief Financial Officer | Appointed | 2023-08-08 |
| Gloria M. McCarthy | Special Advisor to the Chief Executive Officer | Appointed | 2023-02-22 |
| Deanna Strable-Soethout | independent director | Appointed | 2022-10-25 |
Leadership
- Mark B. Kaye CFO
- Ronald W. Penczek Chief Accounting Officer
- Amy W. Schulman Board Member
- Deanna Strable-Soethout Board Member
- Steven H. Collis Board Member
- Susan Dodson DeVore Board Member
Key facts
CIK
1156039
CUSIP
036752103
13F (30d)
429 filings
405 filers
Visit website
Investor relations